TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$55 Million


Follow-on Offering

Bookrunner, February 2015

Confidentially Marketed Public Offering

TherapeuticsMD is a healthcare company focused on developing women’s health products using its patented SYMBODA technology platform. The Company is currently developing advanced hormone therapy pharmaceutical products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes and vaginal dryness. The Company is developing these product candidates, which contain estradiol and progesterone alone or in combination, with the aim of providing equivalent efficacy at lower doses. TherapeuticsMD also manufactures and distributes branded and generic prescription prenatal vitamins, as well as OTC vitamins and cosmetics